Literature DB >> 2028711

Thyroid function and autoimmune manifestations in insulin-dependent diabetes mellitus during and after pregnancy.

K Bech1, M Høier-Madsen, U Feldt-Rasmussen, B M Jensen, L Mølsted-Pedersen, C Kühl.   

Abstract

Insulin-dependent diabetes is associated with other autoimmune diseases and subclinical hypothyroidism has been reported in pregnant diabetic women. We studied the thyroid function of 85 women with diabetes during pregnancy and after delivery, as well as various autoantibodies. During pregnancy, thyroid microsomal antibodies were present in 17/85, antibodies against thyroid peroxidase in 16/85, thyroglobulin antibodies in 2/85, parietal cell antibodies in 23/85, adrenal antibodies in 4/77, rheumatoid factor in 15/85, and thyroid-stimulating antibodies in 43/85. Presence of antibodies was not combined with thyroid dysfunction, but TSH and HbA1c was increased (p less than 0.005) in women with thyroid antibodies. The gestational age of the infants was lower (p less than 0.01) in women with positive thyroid-stimulating antibody titre, whereas the ponderal index was only lower in those with peroxidase antibodies (p less than 0.05). After delivery, microsomal and peroxidase antibodies were positive in 10 (17.5%) of 57 patients followed. Six women developed postpartum thyroiditis (10.5%), of whom 5 were positive for both microsomal and peroxidase antibodies; two of those showing a hyperthyroid phase also had positive thyroid-stimulating antibody titre. We conclude that autoantibodies occur with increased incidence in pregnant diabetic women. Thyroid antibodies are related to a slightly reduced thyroid capacity and involve a high risk of postpartum thyroiditis. Further, thyroid antibodies seem to influence the nutritional status of the infant.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2028711     DOI: 10.1530/acta.0.1240534

Source DB:  PubMed          Journal:  Acta Endocrinol (Copenh)        ISSN: 0001-5598


  8 in total

Review 1.  Clinical Recommendations for the Use of Islet Cell Autoantibodies to Distinguish Autoimmune and Non-Autoimmune Gestational Diabetes.

Authors:  Kadri Haller-Kikkatalo; Raivo Uibo
Journal:  Clin Rev Allergy Immunol       Date:  2016-02       Impact factor: 8.667

Review 2.  Autoimmune thyroid disease and pregnancy.

Authors:  N Amino; H Tada; Y Hidaka
Journal:  J Endocrinol Invest       Date:  1996-01       Impact factor: 4.256

3.  Post-partum thyroiditis in a mediterranean population: a prospective study of a large cohort of thyroid antibody positive women at the time of delivery.

Authors:  M Kita; D G Goulis; A Avramides
Journal:  J Endocrinol Invest       Date:  2002-06       Impact factor: 4.256

4.  Prevalence of post-partum thyroiditis in Liguria (Italy): an observational study.

Authors:  U Filippi; R Brizzolara; D Venuti; A Cesarone; V A Maritati; M Podestà; W F Yung; L C Bottaro; A Orselli; A Chiappori; M Schiavo; M Caputo; S Bonassi; M Bagnasco
Journal:  J Endocrinol Invest       Date:  2008-12       Impact factor: 4.256

5.  Evaluation of thyroid dysfunction in pregnant women with gestational and pre-gestational diabetes.

Authors:  Hajieh Shahbazian; Nahid Shahbazian; Mahnaz Rahimi Baniani; Leila Yazdanpanah; Seyed Mahmuod Latifi
Journal:  Pak J Med Sci       Date:  2013-04       Impact factor: 1.088

Review 6.  Autoimmune Abnormalities of Postpartum Thyroid Diseases.

Authors:  Flavia Di Bari; Roberta Granese; Maria Le Donne; Roberto Vita; Salvatore Benvenga
Journal:  Front Endocrinol (Lausanne)       Date:  2017-07-13       Impact factor: 5.555

7.  Prevalence of Subclinical Hypothyroidism in Pregnancy and Its Association With Anti-thyroperoxidase Antibody and the Occurrence of Gestational Diabetes Mellitus.

Authors:  Prakruti Dash; Rajlaxmi Tiwari; Saurav Nayak; Saubhagya K Jena; Manaswini Mangaraj
Journal:  Cureus       Date:  2022-01-10

8.  Diabetes and pregnancy: an endocrine society clinical practice guideline.

Authors:  Ian Blumer; Eran Hadar; David R Hadden; Lois Jovanovič; Jorge H Mestman; M Hassan Murad; Yariv Yogev
Journal:  J Clin Endocrinol Metab       Date:  2013-11       Impact factor: 5.958

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.